127 related articles for article (PubMed ID: 11961664)
1. Assessment of growth inhibition and morphological changes in in vitro and in vivo hepatocellular carcinoma models post treatment with dl1520 adenovirus.
Habib NA; Mitry RR; Sarraf CE; Jiao LR; Havlík R; Nicholls J; Jensen SL
Cancer Gene Ther; 2002 May; 9(5):414-20. PubMed ID: 11961664
[TBL] [Abstract][Full Text] [Related]
2. p53 selective and nonselective replication of an E1B-deleted adenovirus in hepatocellular carcinoma.
Vollmer CM; Ribas A; Butterfield LH; Dissette VB; Andrews KJ; Eilber FC; Montejo LD; Chen AY; Hu B; Glaspy JA; McBride WH; Economou JS
Cancer Res; 1999 Sep; 59(17):4369-74. PubMed ID: 10485485
[TBL] [Abstract][Full Text] [Related]
3. [Anti-tumor effect of E1B55kDa-deleted adenovirus on human hepatocellular carcinoma cell lines].
Zhao J; Lü Y; Guo Y
Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):366-8. PubMed ID: 11810762
[TBL] [Abstract][Full Text] [Related]
4. The cytotoxic effect of E1B 55-kDa mutant adenovirus on human hepatocellular carcinoma cell lines.
Zhao J; Wang H; Wei L; Habib NA; Lu X; Wu M; Guo Y
Cancer Gene Ther; 2001 May; 8(5):333-41. PubMed ID: 11477453
[TBL] [Abstract][Full Text] [Related]
5. Clinical trial of E1B-deleted adenovirus (dl1520) gene therapy for hepatocellular carcinoma.
Habib N; Salama H; Abd El Latif Abu Median A; Isac Anis I; Abd Al Aziz RA; Sarraf C; Mitry R; Havlik R; Seth P; Hartwigsen J; Bhushan R; Nicholls J; Jensen S
Cancer Gene Ther; 2002 Mar; 9(3):254-9. PubMed ID: 11896441
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of a replication-selective adenovirus against ovarian carcinomatosis is dependent on tumor burden, viral replication and p53 status.
Heise C; Ganly I; Kim YT; Sampson-Johannes A; Brown R; Kirn D
Gene Ther; 2000 Nov; 7(22):1925-9. PubMed ID: 11127580
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus X protein sensitizes hepatocellular carcinoma cells to cytolysis induced by E1B-deleted adenovirus through the disruption of p53 function.
Hsieh JL; Wu CL; Lee CH; Shiau AL
Clin Cancer Res; 2003 Jan; 9(1):338-45. PubMed ID: 12538486
[TBL] [Abstract][Full Text] [Related]
8. Potent antitumoral effects of a novel gene-viral therapeutic system CNHK300-mEndostatin in hepatocellular carcinoma.
Li GC; Yang JM; Nie MM; Su CG; Sun LC; Qian YZ; Fang GE; Sham J; Wu MC; Qian QJ
Chin Med J (Engl); 2005 Feb; 118(3):179-85. PubMed ID: 15740644
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of hepatocellular carcinoma with a novel gene-viral therapeutic system CNHK300-murine endostatin].
Li GC; Nie MM; Yang JM; Su CQ; Sun LC; Qian YZ; Sham J; Fang GE; Wu MC; Qian QJ
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):943-8. PubMed ID: 15329284
[TBL] [Abstract][Full Text] [Related]
10. [Therapeutic potential of recombinant adenovirus expressing p53 in hepatocellular carcinoma cell lines].
Guo Y; Zeng Y; Wang K; Zhu X; Luo H; Zheng M; Li M; Chen J
Zhonghua Gan Zang Bing Za Zhi; 2001 Jul; 9 Suppl():43-5. PubMed ID: 11509137
[TBL] [Abstract][Full Text] [Related]
11. In vivo antitumor activity of ONYX-015 is influenced by p53 status and is augmented by radiotherapy.
Rogulski KR; Freytag SO; Zhang K; Gilbert JD; Paielli DL; Kim JH; Heise CC; Kirn DH
Cancer Res; 2000 Mar; 60(5):1193-6. PubMed ID: 10728673
[TBL] [Abstract][Full Text] [Related]
12. Detection of adenovirus and initiation of apoptosis in hepatocellular carcinoma cells after Ad-p53 treatment.
Mitry RR; Sarraf CE; Havlík R; Habib NA
Hepatology; 2000 Apr; 31(4):885-9. PubMed ID: 10733544
[TBL] [Abstract][Full Text] [Related]
13. [In vitro gene therapy of hepatocellular carcinoma using replication-defective and tumor-specific replication-competent adenovirus carrying interleukin-12 gene].
Wang XH; Yang JM; Cui ZF; Wang WG; Wu MC; Qian QJ
Zhonghua Zhong Liu Za Zhi; 2004 Oct; 26(10):581-4. PubMed ID: 15634515
[TBL] [Abstract][Full Text] [Related]
14. Oncolytic activity of the E1B-55 kDa-deleted adenovirus ONYX-015 is independent of cellular p53 status in human malignant glioma xenografts.
Geoerger B; Grill J; Opolon P; Morizet J; Aubert G; Terrier-Lacombe MJ; Bressac De-Paillerets B; Barrois M; Feunteun J; Kirn DH; Vassal G
Cancer Res; 2002 Feb; 62(3):764-72. PubMed ID: 11830531
[TBL] [Abstract][Full Text] [Related]
15. Target gene therapy for alpha-fetoprotein-producing hepatocellular carcinoma by E1B55k-attenuated adenovirus.
Ohashi M; Kanai F; Tateishi K; Taniguchi H; Marignani PA; Yoshida Y; Shiratori Y; Hamada H; Omata M
Biochem Biophys Res Commun; 2001 Mar; 282(2):529-35. PubMed ID: 11401492
[TBL] [Abstract][Full Text] [Related]
16. 2-Chloroethyl-3-sarcosinamide-1-nitrosourea (SarCNU) inhibits prostate carcinoma cell growth via p53-dependent and p53-independent pathways.
Huynh H; Nguyen TH; Panasci L; Do P
Cancer; 2004 Dec; 101(12):2881-91. PubMed ID: 15529313
[TBL] [Abstract][Full Text] [Related]
17. p53 gene therapy in a rat model of hepatocellular carcinoma: intra-arterial delivery of a recombinant adenovirus.
Anderson SC; Johnson DE; Harris MP; Engler H; Hancock W; Huang WM; Wills KN; Gregory RJ; Sutjipto S; Wen SF; Lofgren S; Shepard HM; Maneval DC
Clin Cancer Res; 1998 Jul; 4(7):1649-59. PubMed ID: 9676839
[TBL] [Abstract][Full Text] [Related]
18. Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial.
Mulvihill S; Warren R; Venook A; Adler A; Randlev B; Heise C; Kirn D
Gene Ther; 2001 Feb; 8(4):308-15. PubMed ID: 11313805
[TBL] [Abstract][Full Text] [Related]
19. Specific systemic nonviral gene delivery to human hepatocellular carcinoma xenografts in SCID mice.
Wolschek MF; Thallinger C; Kursa M; Rössler V; Allen M; Lichtenberger C; Kircheis R; Lucas T; Willheim M; Reinisch W; Gangl A; Wagner E; Jansen B
Hepatology; 2002 Nov; 36(5):1106-14. PubMed ID: 12395320
[TBL] [Abstract][Full Text] [Related]
20. Efficacy with a replication-selective adenovirus plus cisplatin-based chemotherapy: dependence on sequencing but not p53 functional status or route of administration.
Heise C; Lemmon M; Kirn D
Clin Cancer Res; 2000 Dec; 6(12):4908-14. PubMed ID: 11156251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
